22nd Century integrates CBD company to grow its hemp/cannabis franchise faster

US firm 22nd Century has begun integration with GVB Biopharma, one of the largest CBD suppliers globally, as part of a plan to grow its hemp/cannabis franchise rapidly.

It exchanged stock worth around $65m for control of the Las Vegas–based CBD company in April. The company added that the aggregate consideration for the transaction consisted of the assumption of approximately $4.5m of debt, GVB’s closing costs, and the issuance to GVB of 32.9m unregistered shares of 22nd Century common stock.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo